About Nabla
AI company
AI Focus Areas
- Ambient clinical documentation
- Agentic AI assistants for healthcare
- Open-source LLM fine-tuning for medical contexts
- Privacy-preserving, on-prem healthcare AI
Key Products
- Nabla Copilot (clinical note-taking assistant)
- Nabla agentic assistant platform for clinicians
Market Position
Nabla is part of a fast-growing cohort of ambient documentation startups, but stands out through its early work with GPT-3/4 and its strategic pivot toward open-source models (e.g., LLaMA, Mistral) to reduce dependence on proprietary US APIs. It competes with Scribe, Abridge, Nuance DAX, and Big Tech’s healthcare initiatives. Its team includes veterans from Wit.ai and Facebook AI, giving it strong NLP and product chops. Nabla’s traction with European and US clinicians, combined with a focus on safety, auditability, and local hosting options, makes it a credible challenger in a space where regulatory and trust barriers are high.
AGI Relevance
Healthcare is a litmus test for whether AGI-like systems can be made safe and reliable in high-stakes environments. Nabla’s insistence on using models as assistants, not autonomous diagnosticians, reflects a cautious approach to alignment and responsibility. By fine-tuning open-source models for documentation and workflow support, Nabla helps demonstrate how powerful AI can operate under strict privacy constraints and domain-specific guidelines. Its evolution toward ‘agentic’ capabilities—initiating EHR actions, cross-referencing records, and proactively suggesting follow-ups—mirrors broader trends in building AI teammates rather than tools, which will be central to AGI deployment strategies.
Investment Highlights
Raised earlier rounds totaling ~$19M before a $24M Series B in early 2024 led by Cathay Innovation with participation from Zebox Ventures and existing backers, valuing the company at around $180M post-money. A June 2025 Series C of $70M led by HV Capital and Highland Europe, with DST Global and others, reportedly brought total funding to ~$120M as Nabla scaled its AI assistant across 130+ healthcare organizations and tens of thousands of clinicians.
